Cargando…
The soluble ST2 levels in patients with depression and comorbid heart failure
INTRODUCTION: Depression in HF has become a major issue as the burden of HF has continued to increase, and many studies have suggested poorer outcomes in HF patients reporting depression. The prevalence of major depression in HF is about 20–40 %, which is 4–5 % higher than in the normal population....
Autores principales: | Sikora, A., Fedorov, S., Vynnyk, M., Pustovoyt, M., Pityk, O., Bezuk, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565798/ http://dx.doi.org/10.1192/j.eurpsy.2022.314 |
Ejemplares similares
-
The power of multimodal antidepressants: decrease of soluble ST2 blood level in patients with depression and comorbid heart failure
por: Sikora, A. K., et al.
Publicado: (2023) -
Effect of vortioxetine on proinflammatory cytokine levels in patients with heart failure and comorbid depression
por: Sikora, A., et al.
Publicado: (2021) -
A Case of Severe Somatized Depression in a Young Adult: Diagnostic Challenges
por: Pityk, O. M., et al.
Publicado: (2023) -
Optimizing the Correction of Depressive Disorders in Patients with Primary Hypothyroidism
por: Pityk, O. M.
Publicado: (2023) -
Spice related catatonia and its treatment: The case study
por: Pityk, O., et al.
Publicado: (2021)